GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Beneish M-Score

U2Bio Co (XKRX:221800) Beneish M-Score : -1.66 (As of May. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.66 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for U2Bio Co's Beneish M-Score or its related term are showing as below:

XKRX:221800' s Beneish M-Score Range Over the Past 10 Years
Min: -3.9   Med: -2.31   Max: -1.66
Current: -1.66

During the past 9 years, the highest Beneish M-Score of U2Bio Co was -1.66. The lowest was -3.90. And the median was -2.31.


U2Bio Co Beneish M-Score Historical Data

The historical data trend for U2Bio Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co Beneish M-Score Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -2.51 -3.58 -1.68 -3.90 -1.66

U2Bio Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Beneish M-Score - -3.90 - -1.66

Competitive Comparison of U2Bio Co's Beneish M-Score

For the Diagnostics & Research subindustry, U2Bio Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U2Bio Co's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where U2Bio Co's Beneish M-Score falls into.



U2Bio Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of U2Bio Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.6269+0.528 * 1.4462+0.404 * 2.0012+0.892 * 0.4462+0.115 * 0.8645
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 2.8959+4.679 * 0.065052-0.327 * 0.5767
=-1.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was ₩7,391 Mil.
Revenue was ₩30,792 Mil.
Gross Profit was ₩8,219 Mil.
Total Current Assets was ₩45,172 Mil.
Total Assets was ₩49,199 Mil.
Property, Plant and Equipment(Net PPE) was ₩1,549 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩919 Mil.
Selling, General, & Admin. Expense(SGA) was ₩3,849 Mil.
Total Current Liabilities was ₩8,003 Mil.
Long-Term Debt & Capital Lease Obligation was ₩192 Mil.
Net Income was ₩646 Mil.
Gross Profit was ₩0 Mil.
Cash Flow from Operations was ₩-2,555 Mil.
Total Receivables was ₩10,183 Mil.
Revenue was ₩69,013 Mil.
Gross Profit was ₩26,639 Mil.
Total Current Assets was ₩47,873 Mil.
Total Assets was ₩51,028 Mil.
Property, Plant and Equipment(Net PPE) was ₩1,871 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩888 Mil.
Selling, General, & Admin. Expense(SGA) was ₩2,979 Mil.
Total Current Liabilities was ₩14,634 Mil.
Long-Term Debt & Capital Lease Obligation was ₩105 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(7391.243 / 30792.037) / (10182.571 / 69013.134)
=0.240037 / 0.147545
=1.6269

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(26638.76 / 69013.134) / (8218.566 / 30792.037)
=0.385996 / 0.266906
=1.4462

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (45172.072 + 1548.977) / 49199.391) / (1 - (47873.266 + 1870.682) / 51028.368)
=0.050373 / 0.025171
=2.0012

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=30792.037 / 69013.134
=0.4462

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(887.971 / (887.971 + 1870.682)) / (918.866 / (918.866 + 1548.977))
=0.321886 / 0.372336
=0.8645

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(3849.314 / 30792.037) / (2979.184 / 69013.134)
=0.12501 / 0.043168
=2.8959

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((191.958 + 8003.148) / 49199.391) / ((104.637 + 14634.473) / 51028.368)
=0.166569 / 0.288841
=0.5767

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(645.895 - 0 - -2554.6) / 49199.391
=0.065052

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

U2Bio Co has a M-score of -1.66 signals that the company is likely to be a manipulator.


U2Bio Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of U2Bio Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


U2Bio Co (XKRX:221800) Business Description

Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines